首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2051273

肌注疫苗佐劑市場：依佐劑類型、最終用戶、應用、通路和地區分類

Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, By End-users, By Applications, By Distribution Channels By Region

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，肌肉注射疫苗佐劑市場規模估計為8.454億美元，預計2033年將達到13.486億美元。預計2026年至2033年，該市場將以6.9%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	8.454億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.90%	2033年市場規模預測：	13.486億美元

疫苗被認為是預防和控制感染疾病最有效的方法之一。這主要是因為疫苗能夠針對特定病原體並刺激免疫系統。此外，疫苗價格低廉，可以同時用於治療多種疾病。

市場動態

受多種因素影響，全球肌注疫苗佐劑市場預計在預測期內將顯著成長。這些因素包括對安全有效疫苗的需求不斷成長、該領域持續創新以及來自公共和私營部門投資者的資金投入。人口老化和慢性病盛行率上升也是推動全球疫苗佐劑市場成長的主要動力。此外，眾多醫院和其他醫療機構的存在預計也將促進預測期內的市場成長。同時，新治療方法的出現也預計將進一步加速市場成長。

另一方面，佐劑的副作用和毒性預計將成為阻礙市場成長的因素。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球肌肉注射疫苗佐劑市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球肌肉注射疫苗佐劑市場」報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
透過分析全球肌肉注射疫苗佐劑市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

市場動態
- 促進因素
  - 人口老化和慢性病盛行率不斷上升
  - 政府加強疫苗接種建議
- 抑制因子
  - 輔助治療的副作用和毒性
- 機會
  - 該領域的研究和開發活動活性化
影響分析
主要亮點
監管趨勢
產品上市及核准
PEST分析
波特的分析
併購情景

第4章全球肌肉注射疫苗佐劑市場：依佐劑類型分類，2021-2033年

油基佐劑
基於脂質體的佐劑
基於脂質體的佐劑
礦物基佐劑
其他

第5章全球肌肉注射疫苗佐劑市場：依最終用戶分類，2021-2033年

兒童
成人
老年人

第6章全球肌肉注射疫苗佐劑市場：依應用領域分類，2021-2033年

感染疾病
癌症
其他

第7章全球肌肉注射疫苗佐劑市場：依通路分類，2021-2033年

醫院
診所
研究中心

第8章全球肌肉注射疫苗佐劑市場：依地區分類，2021-2033年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 南非
- 北非
- 中非

第9章競爭情勢

Novavax, Inc.
Adjuvance Technologies, Inc.
Invivogen
Vaxine Pty Ltd.
SEPPIC
SPI Pharma, Inc.
Agenus Inc.
Avanti Polar Lipids, Inc.
CSL Limited
OZ Biosciences

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5650

Intramuscular Vaccine Adjuvants Market is estimated to be valued at USD 845.4 Mn in 2026 and is expected to reach USD 1,348.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 845.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.90%	2033 Value Projection:	USD 1,348.6 Mn

Vaccines are considered as one of the most effective methods for the prevention and control of infectious diseases. This is primarily due to their ability to target specific pathogens and stimulate the immune system. Moreover, these products are also inexpensive and can be used to treat multiple diseases simultaneously.

Market Dynamics

The global intramuscular vaccine adjuvants market is expected to experience substantial growth during the forecast period due to several factors. These include an increased demand for safe and effective vaccines, the ongoing pace of innovation in this field, and financial support from various private and public sector investors. A growing geriatric population coupled with increasing prevalence of chronic diseases are other major drivers fuelling growth of the global vaccine adjuvants market. Moreover, the presence of large numbers of hospitals and other healthcare facilities is also expected to propel market growth during the forecast period. In addition, the emergence of novel therapeutics is further expected to boost market growth.

On the other hand, side-effects and toxicity of adjuvants is expected to hinder the market growth.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global intramuscular vaccine adjuvants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Novavax, Inc., Adjuvance Technologies, Inc., Invivogen, Vaxine Pty Ltd., SEPPIC, SPI Pharma, Inc., Agenus Inc., Avanti Polar Lipids, Inc., CSL Limited, and OZ Biosciences.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global intramuscular vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intramuscular vaccine adjuvants market.

Market Segmentation

Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants (Revenue, USD Mn, 2021 - 2033)
Oil-based Adjuvants
Liposome-based Adjuvants
Polymer-based Adjuvants
Mineral-based Adjuvants
Others
Global Intramuscular Vaccine Adjuvants Market, By End Users (Revenue, USD Mn, 2021 - 2033)
Pediatrics
Adults
Geriatrics
Global Intramuscular Vaccine Adjuvants Market, By Applications (Revenue, USD Mn, 2021 - 2033)
Infectious diseases
Cancer
Others
Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels (Revenue, USD Mn, 2021 - 2033)
Hospitals
Clinics
Research Centers
Global Intramuscular Vaccine Adjuvants Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Global Intramuscular Vaccine Adjuvants Market Companies
Novavax, Inc.
Adjuvance Technologies, Inc.
Invivogen
Vaxine Pty Ltd.
SEPPIC
SPI Pharma, Inc.
Agenus Inc.
Avanti Polar Lipids, Inc.
CSL Limited
OZ Biosciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
- Market Intramuscular Vaccine Adjuvants, By End users
- Market Intramuscular Vaccine Adjuvants, By Applications
- Market Intramuscular Vaccine Adjuvants, By Distribution Channels
- Market Intramuscular Vaccine Adjuvants, By Region
Coherent Opportunity Map (COM)

3. Global Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Growing geriatric population coupled with increasing prevalence of chronic diseases
  - Increased government vaccination recommendations
- Restraints
  - Side-effects and toxicity of adjuvants
- Opportunities
  - Increased research and development activities in this field
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oil-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Mineral-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Intramuscular Vaccine Adjuvants Market, By End Users, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Intramuscular Vaccine Adjuvants Market, By Applications, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Intramuscular Vaccine Adjuvants Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Novavax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Adjuvance Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invivogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vaxine Pty Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SEPPIC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SPI Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agenus Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Avanti Polar Lipids, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
OZ Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views